MicroRNAs are short non-coding RNAs that correlate with the levels of platelet activation which can be utilized as a biomarker when guiding P2Y12 inhibitors therapy. In this literature review, the perspectives of microRNA as a novel biomarker are discussed when guiding P2Y12 inhibitors therapy among the patients with coronary artery disease.
CITATION STYLE
Rytkin, E. I., Mirzaev, K. B., Bure, I. V., & Sychev, D. A. (2019). Micro-RNA as a new biomarker of activity of the cytochrome system P-450: Significance for predicting the antiplatelet action of P2Y12 receptor inhibitors. Terapevticheskii Arkhiv, 91(8), 115–117. https://doi.org/10.26442/00403660.2019.08.000389
Mendeley helps you to discover research relevant for your work.